Skip to main content
. 2018 May 23;596(23):5675–5686. doi: 10.1113/JP275428

Table 1.

Ibuprofen administration to newborns with patent ductus arteriosus – neurodevelopmental outcomes

Treatment comparison Number of participants Study type Time frame Neurodevelopmental outcomes Other outcomes
  • Oral ibuprofen

  • Intravenous ibuprofen(Eras, 2013)

  • N = 30

  • N = 27

  • Randomised controlled trial

  • 18–24 months corrected age

  • Oral and i.v. ibuprofen treatment had similar neurological, neurosensory, and cognitive outcomes at 2 years of age.

  • No comparison between treatment and no treatment.

  • No vision or hearing impairment noted for both ibuprofen groups.

  • Ibuprofen

  • Paracetamol(Oncel, 2017)

  • N = 31

  • N = 30

  • Randomised controlled trial

  • 18–24 months corrected age

  • No significant difference in neurodevelopmental outcomes between paracetamol and ibuprofen treatment.

  • No comparison between treatment and no treatment.

  • Blindness and deafness observed in 1 of the ibuprofen treated newborns.

  • Ibuprofen

  • Indomethacin(Rheinlander, 2010)

  • N = 70

  • N = 71

  • Retrospective

  • 24 months

  • No difference in neurodevelopmental outcomes at 24 months between treatment groups.

  • No comparison between treatment and no treatment.

  • No difference in hearing or vision impairment between indomethacin and ibuprofen groups.

  • Ibuprofen

  • Surgical ligation

  • No treatment(Bourgoin, 2016)

  • N = 248

  • N = 104

  • N = 505

  • Retrospective

  • 24 months

  • Ibuprofen treatment did not improve ‘nonoptimal outcome’ at 24 months in comparison to no treatment.

  • Surgical ligation significantly correlated with neurodevelopmental impairment at 24 months.

  • NB. Children with non‐optimal neuromotor and/or psychomotor assessments were regarded as having an overall ‘non‐optimal neurodevelopmental outcome’.

  • Medical management (ibuprofen/indomethacin)

  • Surgical ligation(Weisz, 2017)

  • N = 570

  • N = 184

  • Retrospective

  • 18–24 months corrected age

  • No difference in neurodevelopmental impairment between surgical ligation and medical treatment in adjusted model.

  • In unadjusted model there was a statistically significant increased risk of moderate‐severe neurodevelopmental impairment, chronic lung disease and retinopathy of prematurity